Loading clinical trials...
Loading clinical trials...
Characterization of Gut Microbiota and Metabolic Profiles in Patients With Helicobacter Pylori Infection and Small Intestinal Bacterial Overgrowth Based on Metagenomic and Metabolomic Analyses
Conditions
Interventions
13C-Urea Breath Test
Hydrogen-Methane Breath Test
Locations
1
China
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian, China
Start Date
January 31, 2024
Primary Completion Date
December 30, 2024
Completion Date
February 28, 2025
Last Updated
March 25, 2026
NCT07550023
NCT07537634
NCT07516262
NCT07335406
NCT07471373
NCT07179159
Lead Sponsor
Zhongshan Hospital (Xiamen), Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions